ADVERTISEMENT
News
Prostate Drug Recalled
01/24/2020
The recall affects dutasteride capsules, 0.5 mg, 30-capsule cartons (NDC 50268-282-13) from lots 25246 (Exp. 2/21), 24532 (Exp. 10/20), and 23647 (Exp. 6/20). The capsules were distributed throughout the United States.
AvKare initiated the recall January 7, 2020. On January 13, 2020, the FDA designated the recall Class II. Under Class II recalls, use of the recalled medication could cause temporary or medically reversible adverse health consequences, or a remote possibility of serious harm.
Dutasteride is available with a prescription to treat symptoms of an enlarged prostate.
—Jolynn Tumolo